Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending July 19, 2015
Race-specific Differences in NLPHL, Does clinical presentation differ?
Tripartite Therapies in Multiple Myeloma, Studying PFS, OS,RR, and QoL
Pegylated Recombinant Factor VIII in Hemophilia A, Safety and efficacy results
Salvage Regimens in Multiple Myeloma, Comparing responses, survival, and AEs
Second Primary Malignancies in Polycythemia Vera, Are leukemic transformations a significant risk?
Must reads for theWeek ending July 12, 2015
TKA for Patients With Bleeding Disorders, Do they have higher rates of complications?
Incidence, Prevalence, Costs, and Unmet Needs of MDS, Taking a new look at the data
Ipilimumab in Melanoma, A study of safe infusion rates
Citrus Consumption in Melanoma, Does it increase risk?
ESA and CSF in Colorectal Cancer, A study of significant risk factors
Must reads for theWeek ending July 5, 2015
Older Patients With Pernicious Anemia, Comparing cancer rates with the general populace
Estrogen Metabolites in CRC, Are they associated with risk?
Filgrastim Preventing Severe Neutropenia in BC, Comparing biosimilar with reference product
Identifying Survival Factors in CRC Patients, One SNP shows significant prognostic power
Preserving Fertility in Women With BC, Is their fertility comparable to the noncancer population?
Must reads for theWeek ending June 28, 2015
FDA Approves Ventana Diagnostic Test, Identifies patients eligible for Xalkori treatment
Radio Frequency Ablation in Inoperable NSCLC, How does it compare with radiotherapy?
Paclitaxel or Docetaxel Regimens in Breast Cancer, Results of a 12-year follow-up
Comorbid Conditions in Lung Cancer Patients, How do they effect survival?
HPV16 Typing in HPV-Positive Women, Comparing tests: cobas versus linear array HPV genotyping
Must reads for theWeek ending June 21, 2015
Breast-Cancer Screening, Viewpoint of the IARC Working Group
Uncommon Mutations in NSCLC, How do mutations affect afatinib activity?
Taxane Chemotherapy in CRPC, Considering the role of AR-V7
Carbohydrate Intake in CRC, Do carbs raise the risk?
Adjuvant and Neoadjuvant Radiation Therapy in Genitourinary Cancers, Tracking the usage trend